Publicacions (187) Publicacions de RAFAEL BALAÑA FOUCE

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines

    Molecules, Vol. 29, Núm. 1

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  4. Evaluating alternative compounds for strongyloidiasis therapy: Novel insights from larval migration inhibition test

    PLoS neglected tropical diseases, Vol. 18, Núm. 10, pp. e0012532

  5. Free Radical Production Induced by Nitroimidazole Compounds Lead to Cell Death in Leishmania infantum Amastigotes

    Molecules, Vol. 29, Núm. 17

  6. In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania

    Tropical Medicine and Infectious Disease, Vol. 9, Núm. 2

  7. New benzimidazole derivative compounds with in vitro fasciolicidal properties

    Parasites and Vectors, Vol. 17, Núm. 1

  8. Polyamine Metabolism for Drug Intervention in Trypanosomatids

    Pathogens, Vol. 13, Núm. 1

  9. Promising effects of 1,8 Cineole to control Giardia lamblia infection: Targeting the inflammation, oxidative stress, and infectivity

    Acta Tropica, Vol. 255

  10. Targeting Trypanothione Metabolism in Trypanosomatids

    Molecules, Vol. 29, Núm. 10

  11. Treatment and Healing of Leishmaniasis in a Wolf in Semi-Captivity Regime from an Educational Center of Zamora Province (Spain)

    Animals, Vol. 14, Núm. 10